查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1824171

益生菌市場：2025-2030 年預測

Probiotics Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

益生菌市場規模：

益生菌市場預計將從 2025 年的 985.85 億美元成長到 2030 年的 1,705.07 億美元，複合年成長率為 11.58%。

益生菌市場涵蓋活菌和酵母，它們對人類和動物的健康有益，特別有助於改善消化器官系統。這些有益微生物能夠增強免疫系統，減少腸道炎症，改善腸道健康，防止蛋白質和脂質的氧化分解，同時減少體內致病菌。

基於市場和健康應用

益生菌在多種健康狀況中展現出治療潛力，其應用範圍已從傳統的消化器官系統擴展到心理健康和神經系統疾病的管理。腸腦關係研究支持益生菌在治療心理健康問題的應用。據醫學權威機構稱，近年來，全球範圍內心理健康問題的發病率顯著上升。

該技術不斷擴展的治療範圍包括支持各種神經系統疾病的診斷和治療，這意味著益生菌的應用領域正在不斷擴大，其效用已超越傳統的消化器官系統健康益處。這種市場多元化正在創造新的市場機遇，同時也支持更廣泛的醫療保健應用。

市場成長的關鍵驅動力

消費者日益增強的健康意識是推動市場擴張的一個根本因素，他們積極尋求健康食品作為日常消費。人們對飲食與健康關係的理解日益加深，推動了對富含益生菌的食品、飲料和膳食補充劑的需求，這些產品既能提供基本的營養，又能促進健康。

人口結構變化，包括人口老化，尤其是在新興經濟體，正在創造對健康保健產品的持續需求。可支配收入水準的提高和生活方式的改變推動了高級產品的普及，而食品消費模式的改變則推動益生菌被納入日常飲食中。

全球年輕人健身和健康的趨勢正在推動營養補充劑行業的顯著成長。注重健康的消費者擴大將益生菌納入健身計劃和整體健康策略中，從而為特殊配方創造了持續的市場需求。

產品創新擴展到巧克力、餅乾、飲料和食品等不同類別，正在擴大市場准入和消費者接受度。這些創新提供了多種消費選擇，以滿足不同的偏好和生活方式需求。

市場區隔與分佈

由於加工食品消費量不斷成長、不良生活方式選擇以及衛生部門和媒體不斷加強的營養教育，機能性食品和飲料領域有望保持顯著的市場佔有率。這類產品既有益健康，也易於融入現有的飲食習慣。

由於飲食模式的改變導致肉類消費增加，尤其是在新興經濟體，動物飼料應用顯示出巨大的成長潛力。益生菌在畜牧生產可確保動物健康，同時應對疾病爆發問題，並提高肉類和生產效率。

受健身和健康意識的推動，尤其是年輕一代，營養補充劑行業正在經歷顯著成長。針對特定健康目的的益生菌菌株的先進研發，進一步加速了該領域的市場擴張。

區域市場分析

由於印度和中國等新興經濟體的需求不斷成長，亞太地區擁有巨大的成長潛力。人口快速成長、可支配收入不斷提高以及人們對健康益處的認知不斷增強，推動市場擴張。養樂多等新興市場品牌正成功滲透到該地區市場，推動整個品類的發展。

北美地區製造商在化妝品和醫藥應用領域投入巨資，帶來了巨大的成長機會。該地區先進的科研基礎設施和注重健康的消費者支持高級產品的採用和創新發展。

菌株類型及成分分析

乳酸桿菌和雙歧桿菌是全球食品和飼料領域最常使用的非芽孢益生菌。這些菌株已證實在乳製品中有效，可提高乳糖耐受性和抗致病菌能力，同時支持整體腸道健康。

細菌部分佔據主導市場佔有率，因為它具有廣泛的健康益處，例如增加乳糖酶的產生、預防腹瀉、預防免疫系統疾病、增強乳酸桿菌免疫力等。其他微生物包括釀酒酵母、大腸桿菌和腸球菌，可提供專門的應用。

市場限制和投資挑戰

高昂的研發成本是市場進入和產品開發的一大障礙。建立實驗室、購買研究設備以及招募訓練有素的專業人員都需要大量的初始投資，而且由於益生菌產品與健康密切相關，其回報可能無法立即顯現。

科漢森、達能、養樂多和雀巢等現有市場參與者已實施了全面的研發策略，為新參與企業設置了競爭壁壘。益生菌菌株開發和測試的資本密集性質限制了參與企業市場。

競爭格局與策略發展

主要市場參與企業包括養樂多本社株式會社、達能公司、雀巢公司、Probi AB、Lifeway Foods、BioGaia、Mother Dairy Fruit and Vegetable Pvt. Ltd.、Arla Foods AMBA、i-Health, Inc. 和 Chr. Hansen Holding A/S。這些公司正在實施多元化成長策略，包括產品開發、策略夥伴關係和市場擴張舉措。

戰略產業影響

對於營養補充劑行業的專業人士來說，益生菌市場代表著機能性食品、膳食補充劑和治療用途交匯的機會。成功的關鍵在於平衡創新投資與市場准入，同時滿足消費者在食品、補充劑和特殊健康應用領域的多樣化需求。

市場向心理健康應用和先進菌株開發方向發展，為開發針對特定健康狀況的益生菌解決方案的公司提供了機會，同時透過易於獲取的產品形式保持廣泛的消費者吸引力。

本報告的主要優點

  • 深刻分析：獲得涵蓋主要地區和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局：了解主要企業所採用的策略策略，並了解正確策略的市場滲透潛力。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力來制定策略決策，在動態環境中開闢新的業務流和收益。
  • 受眾廣泛：對於新興企業、研究機構、顧問、中小企業和大型企業來說都是有益且具成本效益的。

它有什麼用途？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

調查範圍

  • 實際數據為2022年至2024年，預測數據為2025年至2030年
  • 成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 收益成長和預測細分市場和區域分析（包括國家）
  • 公司概況（策略、產品、財務、主要發展等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 經營狀況

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

第5章 益生菌市場（依成分）

  • 介紹
  • 細菌
  • 酵母菌

6. 益生菌市場（按功能）

  • 介紹
  • 常規的
  • 預防保健
  • 治療

7. 益生菌市場類型

  • 介紹
  • 乳酸菌
  • 鏈球菌
  • 雙歧桿菌
  • 孢子形成者
  • 其他

第8章益生菌市場（按應用）

  • 介紹
  • 機能性食品和飲料
  • 營養補充品
  • 動物飼料

9. 益生菌市場（按最終用戶）

  • 介紹
  • 人類益生菌
  • 動物益生菌

第 10 章益生菌市場（按地區）

  • 介紹
  • 北美洲
    • 按材質
    • 按功能
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按材質
    • 按功能
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 按材質
    • 按功能
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家
      • 英國
      • 德國
      • 法國
      • 西班牙
      • 其他
  • 中東和非洲
    • 按材質
    • 按功能
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 按材質
    • 按功能
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家
      • 中國
      • 日本
      • 印度
      • 韓國
      • 台灣
      • 其他

第11章競爭格局及分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第12章：公司簡介

  • Yakult Honsha Co., Ltd.
  • Danone SA
  • Nestle SA
  • Probi AB
  • Lifeway Foods
  • BioGaia
  • Mother Dairy Fruit and Vegetable Pvt. Ltd.
  • Arla Foods AMBA
  • i-Health, Inc.,
  • Chr. Hansen Holding A/S

第13章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061610449

Probiotics Market Size:

The Probiotics Market is expected to grow from USD 98.585 billion in 2025 to USD 170.507 billion in 2030, at a CAGR of 11.58%.

The probiotics market encompasses live bacteria and yeasts that provide health benefits to humans and animals, particularly through digestive system improvement. These beneficial microorganisms strengthen immune systems, reduce intestinal inflammation, improve gut health, and protect against oxidative destruction of proteins and lipids while reducing pathogenic organisms in the body.

Market Foundation and Health Applications

Probiotics demonstrate therapeutic potential across multiple health conditions, extending beyond traditional digestive applications into mental health and neurological disorder management. The gut-brain connection research supports probiotic applications in addressing mental health conditions, which have experienced significant global prevalence increases over recent years according to health organizations.

The technology's expanding therapeutic scope includes diagnosis and treatment support for various neurological disorders, representing a growing application area that extends probiotic utility beyond conventional digestive health benefits. This diversification creates new market opportunities while supporting broader healthcare applications.

Primary Market Growth Drivers

Increasing health awareness represents the fundamental driver of market expansion, as consumers actively seek healthy food products for daily consumption. The growing understanding of diet-health relationships drives demand for probiotic-enhanced foods, beverages, and dietary supplements that provide both basic nutrition and health enhancement benefits.

Demographic changes including aging populations, particularly in developing economies, create sustained demand for health-supporting products. Rising disposable income levels and lifestyle changes support premium product adoption, while changing food consumption patterns drive probiotic integration into daily dietary routines.

The fitness and wellness trend among younger global populations drives notable growth in the dietary supplements segment. Health-conscious consumers increasingly incorporate probiotics into fitness regimens and general wellness strategies, creating sustained market demand for specialized formulations.

Product innovation expansion into diverse categories including chocolates, biscuits, beverages, and various food products broadens market accessibility and consumer adoption opportunities. These innovations provide multiple consumption options that cater to different preferences and lifestyle requirements.

Application Segmentation and Market Distribution

The functional food and beverages segment maintains significant market share through rising processed food consumption, poor lifestyle patterns, and increased nutritional education from health authorities and media. This segment benefits from convenient integration into existing dietary habits while providing health benefits.

Animal feed applications demonstrate substantial growth potential driven by changing dietary patterns leading to increased meat consumption, especially in developing economies. Probiotics in animal husbandry ensure proper animal health while addressing disease outbreak concerns, supporting meat quality and production efficiency.

The dietary supplements segment experiences notable growth through fitness awareness and health consciousness, particularly among younger demographics. Advanced probiotic strain development for specific health purposes further accelerates market expansion in this segment.

Geographic Market Analysis

The Asia Pacific region demonstrates significant growth potential through increasing demand from developing countries including India and China. Rapidly expanding populations, rising disposable income, and growing health benefit awareness drive market expansion. Established brands like Yakult successfully penetrate regional markets, supporting overall category development.

North America represents substantial growth opportunities through significant manufacturer investments in cosmetic and pharmaceutical industry applications. The region's advanced research infrastructure and consumer health awareness support premium product adoption and innovation development.

Strain Types and Ingredient Analysis

Lactobacillus and Bifidobacterium represent the most commonly used non-spore-forming probiotics in food and feed applications globally. These strains demonstrate proven efficacy in dairy products, improving lactose tolerance and pathogenic bacteria resistance while supporting overall gut health.

The bacteria segment maintains dominant market share through extensive health benefits including increased lactase production, diarrhea prevention, immune system disorder prevention, and enhanced Lactobacilli immunity. Additional microorganisms including Saccharomyces cerevisiae, Escherichia coli, and Enterococci provide specialized applications.

Market Constraints and Investment Challenges

High research and development costs present significant barriers to market entry and product development. Laboratory development, research equipment procurement, and trained professional recruitment require substantial initial investments that may not generate immediate returns due to the health-focused nature of probiotic products.

Established market players including Chr. Hansen, Danone, Yakult, and Nestle have implemented comprehensive R&D strategies that create competitive barriers for new entrants. The capital-intensive nature of probiotic strain development and testing limits market participation to well-funded organizations.

Competitive Landscape and Strategic Developments

Major market participants include Yakult Honsha Co., Ltd., Danone S.A., Nestle S.A., Probi AB, Lifeway Foods, BioGaia, Mother Dairy Fruit and Vegetable Pvt. Ltd., Arla Foods AMBA, i-Health, Inc., and Chr. Hansen Holding A/S. These companies implement diverse growth strategies including product development, strategic partnerships, and market expansion initiatives.

Strategic Industry Implications

For nutraceutical industry professionals, the probiotics market represents opportunities at the intersection of functional foods, dietary supplements, and therapeutic applications. Success requires balancing innovation investment with market accessibility while addressing diverse consumer needs across food, supplement, and specialized health applications.

Market evolution toward mental health applications and advanced strain development suggests opportunities for companies developing targeted probiotic solutions that address specific health conditions while maintaining broad consumer appeal through accessible product formats.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Probiotics Market Segmentation:

By Ingredients

  • Bacteria
  • Yeast

By Function

  • Regular
  • Preventive Healthcare
  • Therapeutic

By Type

  • Lactobacillus
  • Streptococcus
  • Bifidobacterium
  • Spore Formers
  • Others

By Application

  • Functional food and beverages
  • Dietary supplements
  • Animal Feed

By End-User

  • Human Probiotics
  • Animal Probiotics

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PROBIOTICS MARKET BY INGREDIENTS

  • 5.1. Introduction
  • 5.2. Bacteria
  • 5.3. Yeast

6. PROBIOTICS MARKET BY FUNCTION

  • 6.1. Introduction
  • 6.2. Regular
  • 6.3. Preventive Healthcare
  • 6.4. Therapeutic

7. PROBIOTICS MARKET BY TYPE

  • 7.1. Introduction
  • 7.2. Lactobacillus
  • 7.3. Streptococcus
  • 7.4. Bifidobacterium
  • 7.5. Spore Formers
  • 7.6. Others

8. PROBIOTICS MARKET BY APPLICATION

  • 8.1. Introduction
  • 8.2. Functional food and beverages
  • 8.3. Dietary supplements
  • 8.4. Animal Feed

9. PROBIOTICS MARKET BY END-USER

  • 9.1. Introduction
  • 9.2. Human Probiotics
  • 9.3. Animal Probiotics

10. PROBIOTICS MARKET BY GEOGRAPHY

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. By Ingredients
    • 10.2.2. By Function
    • 10.2.3. By Type
    • 10.2.4. By Application
    • 10.2.5. By End-User
    • 10.2.6. By Country
      • 10.2.6.1. USA
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. South America
    • 10.3.1. By Ingredients
    • 10.3.2. By Function
    • 10.3.3. By Type
    • 10.3.4. By Application
    • 10.3.5. By End-User
    • 10.3.6. By Country
      • 10.3.6.1. Brazil
      • 10.3.6.2. Argentina
      • 10.3.6.3. Others
  • 10.4. Europe
    • 10.4.1. By Ingredients
    • 10.4.2. By Function
    • 10.4.3. By Type
    • 10.4.4. By Application
    • 10.4.5. By End-User
    • 10.4.6. By Country
      • 10.4.6.1. United Kingdom
      • 10.4.6.2. Germany
      • 10.4.6.3. France
      • 10.4.6.4. Spain
      • 10.4.6.5. Others
  • 10.5. Middle East and Africa
    • 10.5.1. By Ingredients
    • 10.5.2. By Function
    • 10.5.3. By Type
    • 10.5.4. By Application
    • 10.5.5. By End-User
    • 10.5.6. By Country
      • 10.5.6.1. Saudi Arabia
      • 10.5.6.2. UAE
      • 10.5.6.3. Others
  • 10.6. Asia Pacific
    • 10.6.1. By Ingredients
    • 10.6.2. By Function
    • 10.6.3. By Type
    • 10.6.4. By Application
    • 10.6.5. By End-User
    • 10.6.6. By Country
      • 10.6.6.1. China
      • 10.6.6.2. Japan
      • 10.6.6.3. India
      • 10.6.6.4. South Korea
      • 10.6.6.5. Taiwan
      • 10.6.6.6. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 11.1. Major Players and Strategy Analysis
  • 11.2. Market Share Analysis
  • 11.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 11.4. Competitive Dashboard

12. COMPANY PROFILES

  • 12.1. Yakult Honsha Co., Ltd.
  • 12.2. Danone S.A
  • 12.3. Nestle S.A
  • 12.4. Probi AB
  • 12.5. Lifeway Foods
  • 12.6. BioGaia
  • 12.7. Mother Dairy Fruit and Vegetable Pvt. Ltd.
  • 12.8. Arla Foods AMBA
  • 12.9. i-Health, Inc.,
  • 12.10. Chr. Hansen Holding A/S

13. APPENDIX

  • 13.1. Currency
  • 13.2. Assumptions
  • 13.3. Base and Forecast Years Timeline
  • 13.4. Key benefits for the stakeholders
  • 13.5. Research Methodology
  • 13.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES